W
IMGN

Wealthfront’s Immunogen Inc IMGN Stock Holding History

Wealthfront’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-9
Closed – – 1134
2015
Q3 		$0 Buy
+9
New +$132 ﹤0.01% 1479

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Wealthfront's IMGN Position: Q4 2015 in Review

Wealthfront sold out of Immunogen Inc (IMGN) in Q4 2015, closing a stake of 9 shares.

Wealthfront first reported a position in IMGN in Q3 2015 and held it in 1 quarter. The position peaked at $0 in Q3 2015. 152 funds tracked by Wall St. Rank hold IMGN as of Q4 2015.

  • Wealthfront reported no remaining Immunogen Inc position as of Q4 2015 after selling out during the quarter.
  • Wealthfront sold 9 Immunogen Inc shares in Q4 2015.
  • Wealthfront first reported a position in Immunogen Inc in Q3 2015 and held it in 1 quarter.
  • Wealthfront's Immunogen Inc position peaked at $0 in Q3 2015.
  • 152 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2015.

Based on Wealthfront's 13F filing for Q4 2015, filed 17 Feb 2016.